The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: The case for neuroglial failure
| dc.contributor.author | Renz-Polster, Herbert | |
| dc.contributor.author | Tremblay, Marie-Ève | |
| dc.contributor.author | Bienzle, Dorothee | |
| dc.contributor.author | Fischer, Joachim E. | |
| dc.date.accessioned | 2024-02-02T19:54:13Z | |
| dc.date.available | 2024-02-02T19:54:13Z | |
| dc.date.copyright | 2022 | en_US |
| dc.date.issued | 2022 | |
| dc.description | We acknowledge with gratitude the many and intense discussions about the pathobiological basis of ME/CFS on Twitter, to which innumerable experts, researchers, organizations, and – not to forget – patients contribute. | en_US |
| dc.description.abstract | Although myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has a specific and distinctive profile of clinical features, the disease remains an enigma because causal explanation of the pathobiological matrix is lacking. Several potential disease mechanisms have been identified, including immune abnormalities, inflammatory activation, mitochondrial alterations, endothelial and muscular disturbances, cardiovascular anomalies, and dysfunction of the peripheral and central nervous systems. Yet, it remains unclear whether and how these pathways may be related and orchestrated. Here we explore the hypothesis that a common denominator of the pathobiological processes in ME/CFS may be central nervous system dysfunction due to impaired or pathologically reactive neuroglia (astrocytes, microglia and oligodendrocytes). We will test this hypothesis by reviewing, in reference to the current literature, the two most salient and widely accepted features of ME/CFS, and by investigating how these might be linked to dysfunctional neuroglia. From this review we conclude that the multifaceted pathobiology of ME/CFS may be attributable in a unifying manner to neuroglial dysfunction. Because the two key features – post exertional malaise and decreased cerebral blood flow – are also recognized in a subset of patients with post-acute sequelae COVID, we suggest that our findings may also be pertinent to this entity. | en_US |
| dc.description.reviewstatus | Reviewed | en_US |
| dc.description.scholarlevel | Faculty | en_US |
| dc.description.sponsorship | For the publication fee we acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding program “Open Access Publikationskosten” as well as by Heidelberg University. M-ET holds a Tier 2 Canada Research Chair in Neurobiology of Aging and Cognition. DB holds a University Research Chair in Veterinary Pathology. | en_US |
| dc.identifier.citation | Renz-Polster, H., Tremblay, M-E., Bienzle, D., & Fischer, J. E. (2022). The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: The case for neuroglial failure. Frontiers in Cellular Neuroscience, 16, 888232. https://doi.org/10.3389/fncel.2022.888232 | en_US |
| dc.identifier.uri | https://doi.org/10.3389/fncel.2022.888232 | |
| dc.identifier.uri | http://hdl.handle.net/1828/15921 | |
| dc.language.iso | en | en_US |
| dc.publisher | Frontiers in Cellular Neuroscience | en_US |
| dc.subject | chronic fatigue syndrome | |
| dc.subject | myalgic encephalomyelitis | |
| dc.subject | neuroinflammation | |
| dc.subject | glia | |
| dc.subject | microglia | |
| dc.subject | astrocytes | |
| dc.subject | oligodendrocytes | |
| dc.subject | blood brain barrier | |
| dc.subject | Centre for Advanced Materials and Related Technology (CAMTEC) | |
| dc.subject.department | Division of Medical Sciences | |
| dc.subject.department | School of Medical Sciences | |
| dc.title | The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: The case for neuroglial failure | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- renz-polster_herbert_FrontCellNeurosci_2022.pdf
- Size:
- 4.42 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 2 KB
- Format:
- Item-specific license agreed upon to submission
- Description: